Non-Catalytic Inhibitors of the p38/MK2 Interface: Repurposing Approved Drugs to Target Neuroinflammation in Alzheimer’s Disease
Year: 2025
Type: article
Language: en
Topic: Melanoma and MAPK Pathways
Authors and affiliations:
raw_author_name: Maylynn Hu
raw_affiliation_strings: Department of Pharmacology and Chemical Biology
Emory University School of Medicine, Emory University
Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Emory University, Atlanta, Georgia 30322, United States
raw_author_name: Andrew Li
raw_affiliation_strings: Department of Pharmacology and Chemical Biology
Emory University School of Medicine, Emory University
raw_author_name: Payton Fleming
raw_affiliation_strings: Department of Pharmacology and Chemical Biology
Emory University School of Medicine, Emory University
raw_author_name: Julia Gralla
raw_affiliation_strings: Department of Pharmacology and Chemical Biology
Emory University School of Medicine, Emory University
Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Emory University, Atlanta, Georgia 30322, United States
raw_author_name: Kristos Negrón Terón
raw_affiliation_strings: Department of Pharmacology and Chemical Biology
Emory University School of Medicine, Emory University
raw_author_name: Ying Zhou
raw_affiliation_strings: Department of Psychiatry & Behavioral Sciences Emory University School of Medicine
Department of Psychiatry & Behavioral Sciences Emory University School of Medicine, Atlanta, Georgia 30322, United States
raw_author_name: Eric J. Miller
raw_affiliation_strings: Department of Pharmacology and Chemical Biology
Emory University
Emory University School of Medicine, Emory University
Winship Cancer Institute
Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Emory University, Atlanta, Georgia 30322, United States
raw_author_name: Tyler S. Beyett
raw_affiliation_strings: Department of Pharmacology and Chemical Biology
Emory University
Emory University School of Medicine, Emory University
Winship Cancer Institute
Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Emory University, Atlanta, Georgia 30322, United States
raw_author_name: Zhexing Wen
raw_affiliation_strings: Department of Psychiatry & Behavioral Sciences Emory University School of Medicine
Departments of Cell Biology, Neurology, and Human Genetics
Emory University School of Medicine
raw_author_name: Yuhong Du
raw_affiliation_strings: Department of Pharmacology and Chemical Biology
Emory Chemical Biology Discovery Center
Emory University
Emory University School of Medicine, Emory University
Winship Cancer Institute
raw_author_name: Haian Fu
raw_affiliation_strings: Department of Hematology & Medical Oncology
Department of Pharmacology and Chemical Biology
Emory Chemical Biology Discovery Center
Emory University
Emory University School of Medicine, Emory University
Winship Cancer Institute
raw_author_name: Andrey A. Ivanov
raw_affiliation_strings: Department of Pharmacology and Chemical Biology
Emory Chemical Biology Discovery Center
Emory University
Emory University School of Medicine, Emory University
Winship Cancer Institute
Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Emory University, Atlanta, Georgia 30322, United States